Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 14.84%651.71B | -8.75%2.39T | 5.68%598.02B | -9.27%620.88B | -13.28%600.82B | -15.68%567.52B | 14.70%2.62T | -6.44%565.87B | 9.57%684.32B | 26.71%692.83B |
Cost of revenue | 13.42%524.35B | -6.27%1.97T | 10.13%508.22B | -5.27%515.58B | -13.94%487.89B | -13.31%462.29B | 15.24%2.11T | -4.26%461.49B | 9.34%544.24B | 29.10%566.9B |
Gross profit | 21.04%127.37B | -18.99%413.27B | -13.96%89.81B | -24.83%105.3B | -10.32%112.93B | -24.71%105.23B | 12.51%510.15B | -14.98%104.38B | 10.44%140.08B | 16.98%125.93B |
Operating expense | 5.78%61.49B | 11.60%238.59B | 3.42%59.4B | 10.75%59.82B | 18.31%61.25B | 14.90%58.13B | 15.88%213.8B | 10.83%57.43B | 15.46%54.01B | 21.19%51.77B |
Operating profit | 39.86%65.88B | -41.06%174.68B | -35.23%30.41B | -47.15%45.48B | -30.31%51.68B | -47.18%47.1B | 10.19%296.35B | -33.83%46.95B | 7.50%86.07B | 14.21%74.16B |
Net non-operating interest income (expenses) | -93.80%-4.91B | 25.55%-8.24B | 26.29%-1.89B | 31.93%-2.08B | 45.69%-1.73B | -12.42%-2.53B | -9.02%-11.07B | -16.36%-2.57B | -34.85%-3.06B | -25.30%-3.19B |
Non-operating interest income | 67.11%1.74B | 29.31%5.59B | 28.79%1.73B | 17.60%1.4B | 34.19%1.41B | 42.29%1.04B | 103.10%4.32B | 118.18%1.34B | 130.31%1.19B | 90.91%1.05B |
Non-operating interest expense | 86.02%6.65B | -10.15%13.83B | -7.36%3.62B | -18.02%3.48B | -25.90%3.14B | 19.75%3.58B | 25.32%15.39B | 38.58%3.91B | 52.60%4.25B | 36.96%4.24B |
Net investment income | 86.91%4.86B | -143.90%-3.97B | 125.58%1.02B | 57.67%-6.8B | -105.22%-781M | -81.60%2.6B | -48.81%9.04B | -156.15%-3.97B | -508.75%-16.07B | 326.48%14.96B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 5,375.54%32.69B | 55,717.78%25.12B | 597M | 45M | ||||||
Income from associates and other participating interests | 55.63%58.1B | -87.73%99.61B | -50.29%33.19B | -95.82%7.22B | -92.67%21.86B | -86.39%37.33B | 9.33%811.96B | -70.81%66.77B | -21.10%172.58B | 64.02%298.23B |
Special income (charges) | 65.54%6.84B | 192.09%24.81B | 116.91%1.02B | 187.93%5.44B | 801.98%14.22B | 132.59%4.13B | -178.87%-26.94B | -240.76%-6.05B | -4.93%-6.19B | -107.12%-2.03B |
Less:Other special charges | -65.54%-6.84B | -199.89%-26.81B | -150.81%-3.03B | -187.93%-5.44B | -171.54%-14.22B | 20.03%-4.13B | 172.62%26.84B | 194.31%5.95B | 17.89%6.19B | 169.50%19.87B |
Less:Write off | ---- | 1,881.19%2B | ---- | ---- | ---- | --0 | -96.41%101M | ---- | ---- | ---- |
Other non-operating income (expenses) | -62.05%1.86B | -121.11%-740M | 50.85%-1.65B | -356.19%-2.85B | -133.19%-1.14B | 112.35%4.9B | 121.99%3.51B | -1,388.85%-3.35B | 80.84%1.11B | 183.90%3.44B |
Income before tax | 41.79%132.63B | -70.57%318.84B | -10.83%87.22B | -77.03%53.98B | -78.19%84.11B | -74.38%93.54B | 4.45%1.08T | -68.36%97.81B | -20.39%235B | 41.18%385.58B |
Income tax | 16.19%21.03B | 43.88%83.58B | 144.60%10.95B | -33.33%12.11B | 148.42%42.42B | -1.50%18.1B | 197.92%58.09B | 142.86%4.48B | 56.89%18.16B | 62.35%17.07B |
Net income | 47.94%111.59B | -77.06%235.26B | -18.29%76.26B | -80.69%41.87B | -88.69%41.69B | -78.24%75.43B | 0.74%1.03T | -70.79%93.34B | -23.54%216.84B | 40.33%368.51B |
Net income continuous operations | 47.94%111.59B | -77.06%235.26B | -18.29%76.26B | -80.69%41.88B | -88.69%41.69B | -78.24%75.43B | 0.74%1.03T | -70.79%93.34B | -23.54%216.84B | 40.33%368.5B |
Noncontrolling interests | -30.01%1.36B | -48.08%6.66B | 4.39%1.24B | -33.19%1.69B | -69.23%1.79B | -41.00%1.94B | 47.26%12.83B | -55.94%1.18B | -6.82%2.53B | 145.80%5.82B |
Net income attributable to the company | 50.00%110.23B | -77.42%228.6B | -18.58%75.03B | -81.25%40.18B | -89.00%39.9B | -78.60%73.49B | 0.34%1.01T | -70.92%92.15B | -23.70%214.31B | 39.37%362.68B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 50.00%110.23B | -77.42%228.6B | -18.58%75.03B | -81.25%40.18B | -89.00%39.9B | -78.60%73.49B | 0.34%1.01T | -70.92%92.15B | -23.70%214.31B | 39.37%362.68B |
Gross dividend payment | ||||||||||
Basic earnings per share | 67.59%242.3697 | -76.52%468.13 | -12.63%158.24 | -79.86%84.9 | -88.74%80.37 | -78.65%144.62 | 0.12%1.99K | -71.04%181.11 | -23.94%421.59 | 39.01%713.79 |
Diluted earnings per share | 67.59%242.3697 | -76.52%468.13 | -12.63%158.24 | -79.86%84.9 | -88.74%80.37 | -78.65%144.62 | 0.12%1.99K | -71.03%181.11 | -23.94%421.59 | 39.01%713.79 |
Dividend per share | 0 | -73.08%140 | -52.94%80 | 0 | -82.86%60 | 0 | 7.59%520 | -59.20%170 | 0 | 425.00%350 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |